In particular, it forbids investment in financial instruments issued by companies that are, directly or through subsidiaries, produce weapons that, when used normally, may violate fundamental humanitarian principles, sell military equipment or weapons to countries on the European Union’s arms embargo list, and/or are involved in serious or systematic violations of human rights, severe environmental damage, serious corruption or other particularly serious violations of fundamental ethical norms.